United States Pharmaceuticals

Onconetix Inc (ONCO)

Track

The most recent insider trading activity for Onconetix Inc. occurred in April 2026, involving HRT Financial LP. This entity engaged in a series of both buy and sell transactions during that month. No further insider activity has been reported since April 21, 2026, which is more than three months ago.
Ticker: ONCO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Onconetix Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 21 Apr 2026
Value US$286,148.94 | Price 261.07 | Shares 63,776 (-11.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-22 2026-04-21 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
63,776 -11.4%
261.07
US$286,149 		63,776 -11.4% 261.07 US$286,149
2026-04-21 2026-04-20 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
81,051 +21.8%
374.36
US$3,896,335 		81,051 +21.8% 374.36 US$3,896,335
2026-04-21 2026-04-17 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
26,657 +38.8%
456.31
US$2,487,996 		26,657 +38.8% 456.31 US$2,487,996
2026-04-21 2026-04-16 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
53,867 -27.3%
0.73
US$39,323 		53,867 -27.3% 0.73 US$39,323
2026-04-16 2026-04-15 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
92,554 +88.6%
0.76
US$70,341 		92,554 +88.6% 0.76 US$70,341
2026-04-16 2026-04-14 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
74,350 +246.6%
0.77
US$57,250 		74,350 +246.6% 0.77 US$57,250
2022-08-22 2022-08-22 S Sale
2.3
Hernandez Joseph

CEO

Executive Director Large shareholder
30,269 -1.1%
4.10
US$124,206 		30,269 -1.1% 4.10 US$124,206
2022-08-23 2022-08-19 S Sale
3.3
Shaw Allan
Non-Executive Director
29,636 -100.0%
3.94
US$116,766 		29,636 -100.0% 3.94 US$116,766
2022-08-22 2022-08-19 S Sale
3.3
Henderson Erin

Chief Business Officer

Officer
4,834 -16.3%
3.97
US$19,191 		4,834 -16.3% 3.97 US$19,191
2022-08-22 2022-08-19 S Sale
2.3
Hernandez Joseph

CEO

Executive Director Large shareholder
76,841 -2.8%
4.21
US$323,662 		76,841 -2.8% 4.21 US$323,662
2022-08-22 2022-08-18 S Sale
2.3
Hernandez Joseph

CEO

Executive Director Large shareholder
442,539 -13.8%
4.96
US$2,192,825 		442,539 -13.8% 4.96 US$2,192,825
Explore more

More insider trading research around Onconetix Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America